AHR and metabolic dysfunction-associated steatotic liver disease: Conservation of the AHR, and similarities in AHR-mediated dyslipidemia and metabolic disease between rodents and humans, suggest a common mechanism that may identify novel therapeutic interventions for NAFLD which currently has limited treatment options66.